Ilana Goldberg alias Dr. Root Cause Rupa

Ilana Goldberg is not licensed or approved by Virginia Board of Medicine, Chiropractic Advisory Board to diagnose, treat, or cure autoimmune disease.

autoimmune disease

Supports

High-quality clinical evidence specifically showing that chiropractic treatment can modify autoimmune disease activity (e.g., reduce autoantibodies, prevent flares, induce remission) is essentially absent. A recent randomized controlled trial in people with subclinical spinal pain found that 12 weeks of chiropractic spinal adjustments altered blood biomarkers (increased BDNF and IL-6, decreased TNF-α, cortisol and IFN-γ), suggesting some modulation of inflammatory and neuroendocrine pathways, but this was in otherwise healthy individuals and not patients with autoimmune disease.^[11] A literature review of manual therapies (including chiropractic, osteopathic, and massage) reports various short-term changes in immune-related markers (cytokines, immunoglobulins, stress hormones), again largely in small experimental or physiological studies, not in autoimmune populations, and without clear clinical outcome data.^{[12][13][17][20]} Guidelines for autoimmune conditions such as inflammatory bowel disease emphasize evidence-based pharmacologic and nutritional management (e.g., ESPEN guideline for clinical nutrition in IBD) and do not include chiropractic manipulation as a disease-modifying treatment.^[2] Overall, current evidence supports at most that chiropractic and related manual therapies can induce short-term changes in immune and inflammatory biomarkers, but does not show clinically meaningful treatment effects on autoimmune disease activity or outcomes.

Contradicts

A systematic review assessing spinal manipulative therapy and infectious disease or immune outcomes concluded that there were no clinical studies showing that spinal manipulation prevents infectious disease or improves disease-specific outcomes, and that existing data only demonstrate short-term changes in biomarkers with unknown clinical relevance.^[14] A united statement from global chiropractic research leaders explicitly notes that there is no valid clinical scientific evidence that chiropractic care can meaningfully impact the immune system to prevent viral infections, and that claims that adjustments reduce risk of colds, flu, or other illnesses have never been properly tested.^[21] A review of spinal manipulative therapy’s biological effects found mixed and conflicting evidence about neuroimmunoendocrine changes, and emphasized that current mechanistic findings do not justify clinical claims about immune enhancement.^[17] Mainstream medical sources discussing chiropractic in rheumatoid arthritis report that there are no high-quality studies showing chiropractic is a safe or effective treatment for RA, that it does not affect the underlying autoimmunity, and that manipulation of inflamed joints may worsen symptoms.^[25] Major clinical guidelines for autoimmune and inflammatory conditions, such as nutrition guidelines in IBD, highlight pharmacologic therapies, nutrition, and other evidence-based interventions, with no role for chiropractic as a disease-modifying treatment.^[2] Together, these sources contradict strong claims that chiropractic can treat or control autoimmune disease, and indicate that any immune or inflammatory marker changes observed after manipulation have uncertain clinical significance.

Mainstream view

The mainstream medical and scientific position is that autoimmune diseases are primarily managed with evidence-based pharmacologic therapies (e.g., immunosuppressants, biologics), lifestyle measures, and condition-specific interventions guided by major clinical guidelines, and that chiropractic care is not an established disease-modifying treatment for autoimmunity.^[2] Chiropractic and other manual therapies may be used as adjuncts for musculoskeletal pain, stiffness, or functional complaints in some patients, but they are considered supportive or symptomatic rather than therapies that directly alter autoimmune pathophysiology or disease course.^[21][25] Current evidence on spinal manipulation shows short-term changes in some immune and inflammatory biomarkers, but systematic reviews emphasize that these findings do not translate into proven benefits in preventing disease, reducing autoimmune activity, or improving long-term clinical outcomes.^[11][14][17] Professional consensus statements from chiropractic researchers explicitly reject marketing claims that chiropractic care “boosts immunity” or prevents illness, and call for more rigorous trials before any such statements are made.^[14][21] For autoimmune diseases specifically (such as rheumatoid arthritis, lupus, multiple sclerosis, and inflammatory bowel disease), mainstream guidance does not recommend chiropractic as a primary treatment, and warns that manipulation of actively inflamed joints or unstable spines may pose risks.^[2][25]

In their own wordsView sourceArchived copy

“autoimmune disease”

Rule: Va. Code § 54.1-2900; 18VAC85-20-10

See every doc bro advertising Autoimmune disease

Ilana Goldberg is not licensed or approved by Virginia Board of Medicine, Chiropractic Advisory Board to diagnose, treat, or cure hormone imbalance.

hormone imbalance

Supports

The influencer’s claim is extremely broad and only implicitly suggests that these conditions are interconnected and can be addressed together. Current high‑quality evidence does support that hormone regulation, chronic inflammation, digestive disorders, autoimmune conditions, and metabolic health are biologically interlinked through shared endocrine–immune–metabolic pathways and low‑grade systemic inflammation. Narrative and mechanistic reviews show that chronic inflammatory diseases and metabolic diseases involve coordinated disturbances of energy regulation, neuroendocrine control, and immune activation, leading to insulin resistance, dyslipidemia, hypoandrogenism, mild hypercortisolism, and other metabolic changes, i.e., a shared pathophysiologic network rather than isolated organ problems.^[14] Evidence aggregations on metabolic diseases similarly emphasize the interplay between endocrine dysfunction, immune dysregulation, and chronic inflammation in driving abnormal metabolism, including obesity and metabolic syndrome.^[14] Lifestyle‑focused randomized trials and meta‑analyses (diet, physical activity, Mediterranean‑style patterns, and related behavior programs) show that comprehensive lifestyle interventions can concurrently improve inflammatory markers (C‑reactive protein, IL‑6), abdominal or visceral obesity, and multiple metabolic risk factors in metabolic syndrome and high‑risk cardiometabolic populations, indicating that a unified lifestyle approach can positively affect both inflammation and metabolic health at once.^{[1][2][4][7][8][10][13][15]} There is also growing recognition that gut dysbiosis and microbiome‑driven inflammasome activation (e.g., NLRP3) act as a common node linking digestive disorders (such as inflammatory bowel disease) with systemic inflammation, obesity, metabolic disorders, and some autoimmune phenomena, supporting the idea of a shared digestive–immune–metabolic axis that could be targeted together.^[21] Large narrative and integrative reviews further describe how chronic pain and chronic inflammatory states are associated with intertwined endocrine (HPA axis, insulin, adipokines) and cardiometabolic dysfunction, again reinforcing that multiple chronic conditions often converge on overlapping inflammatory and hormonal pathways that may respond to systemic, rather than purely organ‑specific, strategies.^{[6][11][14][18]}

Contradicts

The claim as stated is vague and could be interpreted as implying that there is a single, general method that can reliably ‘address’ hormone imbalance, chronic inflammation, digestive disorders, autoimmune conditions, and metabolic health together for most people. High‑quality evidence and guidelines do not support such a one‑size‑fits‑all or universally effective intervention across this entire spectrum of conditions. Individual diseases such as hypertension, inflammatory bowel disease, and specific autoimmune or endocrine disorders have detailed, disease‑specific, guideline‑driven management pathways that involve pharmacologic and non‑pharmacologic interventions tailored to the particular condition and person, not a generic global “hormone/inflammation reset.” Standard hypertension management, for example, relies on graded lifestyle measures plus specific antihypertensive drug classes chosen according to comorbidities and risk, and does not endorse a single holistic regimen as sufficient treatment for all patients.^[0] Evidence‑based nutrition guidelines for inflammatory bowel disease emphasize individualized enteral and oral nutrition strategies, careful monitoring, and integration with immunosuppressive and biologic therapies, not the idea that broad metabolic or hormonal approaches alone can reliably control autoimmune digestive inflammation.^[2] Major clinical nutrition guidelines and appropriate‑use criteria stress that complex chronic conditions (including autoimmune and digestive diseases) require structured, multidisciplinary care (nutrition support, pharmacotherapy, sometimes parenteral nutrition) and warn against oversimplified approaches that are not supported by robust trial evidence.^[1][3] More broadly, while lifestyle change, microbiome modulation, and integrative concepts are promising, current trials and systematic reviews rarely show large, uniform benefits across the very different domains of hormonal disorders, autoimmune disease activity, digestive pathology, and metabolic outcomes simultaneously; effects are usually modest, condition‑specific, and variable among individuals. Thus, any suggestion that addressing “hormone imbalance” or “inflammation” in a generic way can reliably treat all these conditions would extend beyond what current evidence substantiates.^{[4][5][7][8][10][15]}

Mainstream view

Mainstream medicine and science recognize that endocrine regulation, chronic inflammation, digestive health, autoimmunity, and metabolic status are deeply interconnected, and that shared mechanisms such as low‑grade inflammation, immune–endocrine cross‑talk, and gut microbiome dysbiosis contribute to multiple chronic diseases.^[6][11][14

In their own wordsView sourceArchived copy

“hormone imbalance”

Rule: Va. Code § 54.1-2900; 18VAC85-20-10

See every doc bro advertising Hormone imbalance and replacement

Ilana Goldberg is not licensed or approved by Virginia Board of Medicine, Chiropractic Advisory Board to diagnose, treat, or cure addressing hormone imbalance, chronic inflammation, digestive disorders, autoimmune conditions, and metabolic health.

addressing hormone imbalance, chronic inflammation, digestive disorders, autoimmune conditions, and metabolic health

Supports

The influencer’s claim is extremely broad and only implicitly suggests that these conditions are interconnected and can be addressed together. Current high‑quality evidence does support that hormone regulation, chronic inflammation, digestive disorders, autoimmune conditions, and metabolic health are biologically interlinked through shared endocrine–immune–metabolic pathways and low‑grade systemic inflammation. Narrative and mechanistic reviews show that chronic inflammatory diseases and metabolic diseases involve coordinated disturbances of energy regulation, neuroendocrine control, and immune activation, leading to insulin resistance, dyslipidemia, hypoandrogenism, mild hypercortisolism, and other metabolic changes, i.e., a shared pathophysiologic network rather than isolated organ problems.^[14] Evidence aggregations on metabolic diseases similarly emphasize the interplay between endocrine dysfunction, immune dysregulation, and chronic inflammation in driving abnormal metabolism, including obesity and metabolic syndrome.^[14] Lifestyle‑focused randomized trials and meta‑analyses (diet, physical activity, Mediterranean‑style patterns, and related behavior programs) show that comprehensive lifestyle interventions can concurrently improve inflammatory markers (C‑reactive protein, IL‑6), abdominal or visceral obesity, and multiple metabolic risk factors in metabolic syndrome and high‑risk cardiometabolic populations, indicating that a unified lifestyle approach can positively affect both inflammation and metabolic health at once.^{[1][2][4][7][8][10][13][15]} There is also growing recognition that gut dysbiosis and microbiome‑driven inflammasome activation (e.g., NLRP3) act as a common node linking digestive disorders (such as inflammatory bowel disease) with systemic inflammation, obesity, metabolic disorders, and some autoimmune phenomena, supporting the idea of a shared digestive–immune–metabolic axis that could be targeted together.^[21] Large narrative and integrative reviews further describe how chronic pain and chronic inflammatory states are associated with intertwined endocrine (HPA axis, insulin, adipokines) and cardiometabolic dysfunction, again reinforcing that multiple chronic conditions often converge on overlapping inflammatory and hormonal pathways that may respond to systemic, rather than purely organ‑specific, strategies.^{[6][11][14][18]}

Contradicts

The claim as stated is vague and could be interpreted as implying that there is a single, general method that can reliably ‘address’ hormone imbalance, chronic inflammation, digestive disorders, autoimmune conditions, and metabolic health together for most people. High‑quality evidence and guidelines do not support such a one‑size‑fits‑all or universally effective intervention across this entire spectrum of conditions. Individual diseases such as hypertension, inflammatory bowel disease, and specific autoimmune or endocrine disorders have detailed, disease‑specific, guideline‑driven management pathways that involve pharmacologic and non‑pharmacologic interventions tailored to the particular condition and person, not a generic global “hormone/inflammation reset.” Standard hypertension management, for example, relies on graded lifestyle measures plus specific antihypertensive drug classes chosen according to comorbidities and risk, and does not endorse a single holistic regimen as sufficient treatment for all patients.^[0] Evidence‑based nutrition guidelines for inflammatory bowel disease emphasize individualized enteral and oral nutrition strategies, careful monitoring, and integration with immunosuppressive and biologic therapies, not the idea that broad metabolic or hormonal approaches alone can reliably control autoimmune digestive inflammation.^[2] Major clinical nutrition guidelines and appropriate‑use criteria stress that complex chronic conditions (including autoimmune and digestive diseases) require structured, multidisciplinary care (nutrition support, pharmacotherapy, sometimes parenteral nutrition) and warn against oversimplified approaches that are not supported by robust trial evidence.^[1][3] More broadly, while lifestyle change, microbiome modulation, and integrative concepts are promising, current trials and systematic reviews rarely show large, uniform benefits across the very different domains of hormonal disorders, autoimmune disease activity, digestive pathology, and metabolic outcomes simultaneously; effects are usually modest, condition‑specific, and variable among individuals. Thus, any suggestion that addressing “hormone imbalance” or “inflammation” in a generic way can reliably treat all these conditions would extend beyond what current evidence substantiates.^{[4][5][7][8][10][15]}

Mainstream view

Mainstream medicine and science recognize that endocrine regulation, chronic inflammation, digestive health, autoimmunity, and metabolic status are deeply interconnected, and that shared mechanisms such as low‑grade inflammation, immune–endocrine cross‑talk, and gut microbiome dysbiosis contribute to multiple chronic diseases.^[6][11][14

In their own wordsView sourceArchived copy

“addressing hormone imbalance, chronic inflammation, digestive disorders, autoimmune conditions, and metabolic health”

Rule: Va. Code § 54.1-2900; 18VAC85-20-10

See every doc bro advertising Hormone imbalance and replacement

Ilana Goldberg is not licensed or approved by Virginia Board of Medicine, Chiropractic Advisory Board to diagnose, treat, or cure A Holistic Approach To HASHIMOTO’S AUTOIMMUNE THYROIDITIS.

A Holistic Approach To HASHIMOTO’S AUTOIMMUNE THYROIDITIS

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“A Holistic Approach To HASHIMOTO’S AUTOIMMUNE THYROIDITIS”

Rule: Va. Code § 54.1-2900; 18VAC85-20-10

See every doc bro advertising Thyroid disease and Hashimoto

Ilana Goldberg is not licensed or approved by Virginia Board of Medicine, Chiropractic Advisory Board to advertise Diagnosing and treating systemic autoimmune diseases, which are outside chiropractic scope. as within their scope of practice.

Diagnosing and treating systemic autoimmune diseases, which are outside chiropractic scope.

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“autoimmune disease”

Rule: Va. Code § 54.1-2900; 18VAC85-20-10

See every doc bro advertising Autoimmune disease

Ilana Goldberg is not licensed or approved by Virginia Board of Medicine, Chiropractic Advisory Board to advertise Functional Medicine for Autoimmune Disease as within their scope of practice.

Functional Medicine for Autoimmune Disease

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“autoimmune disease”

Rule: Va. Code § 54.1-2900; 18VAC85-20-10

Ilana Goldberg is not licensed or approved by Virginia Board of Medicine, Chiropractic Advisory Board to diagnose, treat, or cure digestive disorders.

digestive disorders

Supports

The influencer’s claim is extremely broad and only implicitly suggests that these conditions are interconnected and can be addressed together. Current high‑quality evidence does support that hormone regulation, chronic inflammation, digestive disorders, autoimmune conditions, and metabolic health are biologically interlinked through shared endocrine–immune–metabolic pathways and low‑grade systemic inflammation. Narrative and mechanistic reviews show that chronic inflammatory diseases and metabolic diseases involve coordinated disturbances of energy regulation, neuroendocrine control, and immune activation, leading to insulin resistance, dyslipidemia, hypoandrogenism, mild hypercortisolism, and other metabolic changes, i.e., a shared pathophysiologic network rather than isolated organ problems.^[14] Evidence aggregations on metabolic diseases similarly emphasize the interplay between endocrine dysfunction, immune dysregulation, and chronic inflammation in driving abnormal metabolism, including obesity and metabolic syndrome.^[14] Lifestyle‑focused randomized trials and meta‑analyses (diet, physical activity, Mediterranean‑style patterns, and related behavior programs) show that comprehensive lifestyle interventions can concurrently improve inflammatory markers (C‑reactive protein, IL‑6), abdominal or visceral obesity, and multiple metabolic risk factors in metabolic syndrome and high‑risk cardiometabolic populations, indicating that a unified lifestyle approach can positively affect both inflammation and metabolic health at once.^{[1][2][4][7][8][10][13][15]} There is also growing recognition that gut dysbiosis and microbiome‑driven inflammasome activation (e.g., NLRP3) act as a common node linking digestive disorders (such as inflammatory bowel disease) with systemic inflammation, obesity, metabolic disorders, and some autoimmune phenomena, supporting the idea of a shared digestive–immune–metabolic axis that could be targeted together.^[21] Large narrative and integrative reviews further describe how chronic pain and chronic inflammatory states are associated with intertwined endocrine (HPA axis, insulin, adipokines) and cardiometabolic dysfunction, again reinforcing that multiple chronic conditions often converge on overlapping inflammatory and hormonal pathways that may respond to systemic, rather than purely organ‑specific, strategies.^{[6][11][14][18]}

Contradicts

The claim as stated is vague and could be interpreted as implying that there is a single, general method that can reliably ‘address’ hormone imbalance, chronic inflammation, digestive disorders, autoimmune conditions, and metabolic health together for most people. High‑quality evidence and guidelines do not support such a one‑size‑fits‑all or universally effective intervention across this entire spectrum of conditions. Individual diseases such as hypertension, inflammatory bowel disease, and specific autoimmune or endocrine disorders have detailed, disease‑specific, guideline‑driven management pathways that involve pharmacologic and non‑pharmacologic interventions tailored to the particular condition and person, not a generic global “hormone/inflammation reset.” Standard hypertension management, for example, relies on graded lifestyle measures plus specific antihypertensive drug classes chosen according to comorbidities and risk, and does not endorse a single holistic regimen as sufficient treatment for all patients.^[0] Evidence‑based nutrition guidelines for inflammatory bowel disease emphasize individualized enteral and oral nutrition strategies, careful monitoring, and integration with immunosuppressive and biologic therapies, not the idea that broad metabolic or hormonal approaches alone can reliably control autoimmune digestive inflammation.^[2] Major clinical nutrition guidelines and appropriate‑use criteria stress that complex chronic conditions (including autoimmune and digestive diseases) require structured, multidisciplinary care (nutrition support, pharmacotherapy, sometimes parenteral nutrition) and warn against oversimplified approaches that are not supported by robust trial evidence.^[1][3] More broadly, while lifestyle change, microbiome modulation, and integrative concepts are promising, current trials and systematic reviews rarely show large, uniform benefits across the very different domains of hormonal disorders, autoimmune disease activity, digestive pathology, and metabolic outcomes simultaneously; effects are usually modest, condition‑specific, and variable among individuals. Thus, any suggestion that addressing “hormone imbalance” or “inflammation” in a generic way can reliably treat all these conditions would extend beyond what current evidence substantiates.^{[4][5][7][8][10][15]}

Mainstream view

Mainstream medicine and science recognize that endocrine regulation, chronic inflammation, digestive health, autoimmunity, and metabolic status are deeply interconnected, and that shared mechanisms such as low‑grade inflammation, immune–endocrine cross‑talk, and gut microbiome dysbiosis contribute to multiple chronic diseases.^[6][11][14

In their own wordsView sourceArchived copy

“digestive disorders”

Rule: Va. Code § 54.1-2900; 18VAC85-20-10

See every doc bro advertising IBS, SIBO and gut disorders

Ilana Goldberg is not licensed or approved by Virginia Board of Medicine, Chiropractic Advisory Board to diagnose, treat, or cure chronic inflammation.

chronic inflammation

Supports

The influencer’s claim is extremely broad and only implicitly suggests that these conditions are interconnected and can be addressed together. Current high‑quality evidence does support that hormone regulation, chronic inflammation, digestive disorders, autoimmune conditions, and metabolic health are biologically interlinked through shared endocrine–immune–metabolic pathways and low‑grade systemic inflammation. Narrative and mechanistic reviews show that chronic inflammatory diseases and metabolic diseases involve coordinated disturbances of energy regulation, neuroendocrine control, and immune activation, leading to insulin resistance, dyslipidemia, hypoandrogenism, mild hypercortisolism, and other metabolic changes, i.e., a shared pathophysiologic network rather than isolated organ problems.^[14] Evidence aggregations on metabolic diseases similarly emphasize the interplay between endocrine dysfunction, immune dysregulation, and chronic inflammation in driving abnormal metabolism, including obesity and metabolic syndrome.^[14] Lifestyle‑focused randomized trials and meta‑analyses (diet, physical activity, Mediterranean‑style patterns, and related behavior programs) show that comprehensive lifestyle interventions can concurrently improve inflammatory markers (C‑reactive protein, IL‑6), abdominal or visceral obesity, and multiple metabolic risk factors in metabolic syndrome and high‑risk cardiometabolic populations, indicating that a unified lifestyle approach can positively affect both inflammation and metabolic health at once.^{[1][2][4][7][8][10][13][15]} There is also growing recognition that gut dysbiosis and microbiome‑driven inflammasome activation (e.g., NLRP3) act as a common node linking digestive disorders (such as inflammatory bowel disease) with systemic inflammation, obesity, metabolic disorders, and some autoimmune phenomena, supporting the idea of a shared digestive–immune–metabolic axis that could be targeted together.^[21] Large narrative and integrative reviews further describe how chronic pain and chronic inflammatory states are associated with intertwined endocrine (HPA axis, insulin, adipokines) and cardiometabolic dysfunction, again reinforcing that multiple chronic conditions often converge on overlapping inflammatory and hormonal pathways that may respond to systemic, rather than purely organ‑specific, strategies.^{[6][11][14][18]}

Contradicts

The claim as stated is vague and could be interpreted as implying that there is a single, general method that can reliably ‘address’ hormone imbalance, chronic inflammation, digestive disorders, autoimmune conditions, and metabolic health together for most people. High‑quality evidence and guidelines do not support such a one‑size‑fits‑all or universally effective intervention across this entire spectrum of conditions. Individual diseases such as hypertension, inflammatory bowel disease, and specific autoimmune or endocrine disorders have detailed, disease‑specific, guideline‑driven management pathways that involve pharmacologic and non‑pharmacologic interventions tailored to the particular condition and person, not a generic global “hormone/inflammation reset.” Standard hypertension management, for example, relies on graded lifestyle measures plus specific antihypertensive drug classes chosen according to comorbidities and risk, and does not endorse a single holistic regimen as sufficient treatment for all patients.^[0] Evidence‑based nutrition guidelines for inflammatory bowel disease emphasize individualized enteral and oral nutrition strategies, careful monitoring, and integration with immunosuppressive and biologic therapies, not the idea that broad metabolic or hormonal approaches alone can reliably control autoimmune digestive inflammation.^[2] Major clinical nutrition guidelines and appropriate‑use criteria stress that complex chronic conditions (including autoimmune and digestive diseases) require structured, multidisciplinary care (nutrition support, pharmacotherapy, sometimes parenteral nutrition) and warn against oversimplified approaches that are not supported by robust trial evidence.^[1][3] More broadly, while lifestyle change, microbiome modulation, and integrative concepts are promising, current trials and systematic reviews rarely show large, uniform benefits across the very different domains of hormonal disorders, autoimmune disease activity, digestive pathology, and metabolic outcomes simultaneously; effects are usually modest, condition‑specific, and variable among individuals. Thus, any suggestion that addressing “hormone imbalance” or “inflammation” in a generic way can reliably treat all these conditions would extend beyond what current evidence substantiates.^{[4][5][7][8][10][15]}

Mainstream view

Mainstream medicine and science recognize that endocrine regulation, chronic inflammation, digestive health, autoimmunity, and metabolic status are deeply interconnected, and that shared mechanisms such as low‑grade inflammation, immune–endocrine cross‑talk, and gut microbiome dysbiosis contribute to multiple chronic diseases.^[6][11][14

In their own wordsView sourceArchived copy

“chronic inflammation”

Rule: Va. Code § 54.1-2900; 18VAC85-20-10

Ilana Goldberg is not licensed or approved by Virginia Board of Medicine, Chiropractic Advisory Board to advertise metabolic health as within their scope of practice.

metabolic health

Supports

The influencer’s claim is extremely broad and only implicitly suggests that these conditions are interconnected and can be addressed together. Current high‑quality evidence does support that hormone regulation, chronic inflammation, digestive disorders, autoimmune conditions, and metabolic health are biologically interlinked through shared endocrine–immune–metabolic pathways and low‑grade systemic inflammation. Narrative and mechanistic reviews show that chronic inflammatory diseases and metabolic diseases involve coordinated disturbances of energy regulation, neuroendocrine control, and immune activation, leading to insulin resistance, dyslipidemia, hypoandrogenism, mild hypercortisolism, and other metabolic changes, i.e., a shared pathophysiologic network rather than isolated organ problems.^[14] Evidence aggregations on metabolic diseases similarly emphasize the interplay between endocrine dysfunction, immune dysregulation, and chronic inflammation in driving abnormal metabolism, including obesity and metabolic syndrome.^[14] Lifestyle‑focused randomized trials and meta‑analyses (diet, physical activity, Mediterranean‑style patterns, and related behavior programs) show that comprehensive lifestyle interventions can concurrently improve inflammatory markers (C‑reactive protein, IL‑6), abdominal or visceral obesity, and multiple metabolic risk factors in metabolic syndrome and high‑risk cardiometabolic populations, indicating that a unified lifestyle approach can positively affect both inflammation and metabolic health at once.^{[1][2][4][7][8][10][13][15]} There is also growing recognition that gut dysbiosis and microbiome‑driven inflammasome activation (e.g., NLRP3) act as a common node linking digestive disorders (such as inflammatory bowel disease) with systemic inflammation, obesity, metabolic disorders, and some autoimmune phenomena, supporting the idea of a shared digestive–immune–metabolic axis that could be targeted together.^[21] Large narrative and integrative reviews further describe how chronic pain and chronic inflammatory states are associated with intertwined endocrine (HPA axis, insulin, adipokines) and cardiometabolic dysfunction, again reinforcing that multiple chronic conditions often converge on overlapping inflammatory and hormonal pathways that may respond to systemic, rather than purely organ‑specific, strategies.^{[6][11][14][18]}

Contradicts

The claim as stated is vague and could be interpreted as implying that there is a single, general method that can reliably ‘address’ hormone imbalance, chronic inflammation, digestive disorders, autoimmune conditions, and metabolic health together for most people. High‑quality evidence and guidelines do not support such a one‑size‑fits‑all or universally effective intervention across this entire spectrum of conditions. Individual diseases such as hypertension, inflammatory bowel disease, and specific autoimmune or endocrine disorders have detailed, disease‑specific, guideline‑driven management pathways that involve pharmacologic and non‑pharmacologic interventions tailored to the particular condition and person, not a generic global “hormone/inflammation reset.” Standard hypertension management, for example, relies on graded lifestyle measures plus specific antihypertensive drug classes chosen according to comorbidities and risk, and does not endorse a single holistic regimen as sufficient treatment for all patients.^[0] Evidence‑based nutrition guidelines for inflammatory bowel disease emphasize individualized enteral and oral nutrition strategies, careful monitoring, and integration with immunosuppressive and biologic therapies, not the idea that broad metabolic or hormonal approaches alone can reliably control autoimmune digestive inflammation.^[2] Major clinical nutrition guidelines and appropriate‑use criteria stress that complex chronic conditions (including autoimmune and digestive diseases) require structured, multidisciplinary care (nutrition support, pharmacotherapy, sometimes parenteral nutrition) and warn against oversimplified approaches that are not supported by robust trial evidence.^[1][3] More broadly, while lifestyle change, microbiome modulation, and integrative concepts are promising, current trials and systematic reviews rarely show large, uniform benefits across the very different domains of hormonal disorders, autoimmune disease activity, digestive pathology, and metabolic outcomes simultaneously; effects are usually modest, condition‑specific, and variable among individuals. Thus, any suggestion that addressing “hormone imbalance” or “inflammation” in a generic way can reliably treat all these conditions would extend beyond what current evidence substantiates.^{[4][5][7][8][10][15]}

Mainstream view

Mainstream medicine and science recognize that endocrine regulation, chronic inflammation, digestive health, autoimmunity, and metabolic status are deeply interconnected, and that shared mechanisms such as low‑grade inflammation, immune–endocrine cross‑talk, and gut microbiome dysbiosis contribute to multiple chronic diseases.^[6][11][14

In their own wordsView sourceArchived copy

“metabolic health”

Rule: Va. Code § 54.1-2900; 18VAC85-20-10

Ilana Goldberg is not licensed or approved by Virginia Board of Medicine, Chiropractic Advisory Board to advertise identifying and addressing the root causes of chronic symptoms instead of simply suppressing them as within their scope of practice.

identifying and addressing the root causes of chronic symptoms instead of simply suppressing them

Supports

Guidelines and evidence-based reviews consistently support identifying and treating underlying causes when they are known or suspected, rather than relying only on symptom suppression. ^[1][5][6] For hypertension, major guidelines recommend evaluating for secondary causes and using targeted treatment for modifiable drivers such as obesity, alcohol, sleep apnea, and drug-induced hypertension, which can sometimes cure hypertension or reduce medication burden. ^[17][19][20] The same principle appears in nutrition and pericarditis guidance: clinical nutrition guidelines emphasize diagnosing and treating the cause of nutritional failure or gastrointestinal disease, and colchicine is recommended as part of a cause-directed anti-inflammatory strategy for pericarditis rather than pure symptom masking. ^{[2][3][8][18]} Headache guidelines also support non-drug measures, trigger identification, and prophylaxis, reflecting that chronic symptoms are not always best managed by acute symptom relief alone.

Contradicts

The claim is too broad if interpreted as implying that chronic symptoms should generally be addressed by root-cause treatment instead of symptom control. For chronic tension-type headache, guidelines explicitly recommend analgesics for acute relief and preventive drugs such as amitriptyline, because symptom suppression remains part of standard care and the scientific basis for purely non-drug or cause-finding approaches is limited. ^{[2][4][17][18][19]} In many chronic conditions, the cause is unknown, multifactorial, or not fully modifiable, so clinicians often combine symptom-directed therapy with etiologic evaluation rather than replace one with the other. ^[7] The claim also overstates the evidence if it implies that identifying a single root cause is usually possible or superior across chronic illnesses; evidence quality for broad “root-cause” approaches is variable, and major evidence frameworks emphasize uncertainty, imprecision, and the need for condition-specific data rather than general slogans. ^[6]

Mainstream view

Mainstream medicine supports evaluating chronic symptoms for underlying causes when clinically indicated and treating those causes when found, but it does not endorse abandoning symptom control. ^[5][18][19] The standard approach is combined, condition-specific care: investigate secondary or reversible causes, use targeted disease-modifying treatment when available, and also provide symptomatic treatment to reduce burden and prevent complications. ^[4][20]

In their own wordsView sourceArchived copy

“identifying and addressing the root causes of chronic symptoms instead of simply suppressing them”

Rule: Va. Code § 54.1-2900; 18VAC85-20-10

Ilana Goldberg is not licensed or approved by Virginia Board of Medicine, Chiropractic Advisory Board to advertise using the most advanced diagnostic testing to identify the root causes, a completely personalized treatment protocol is designed as within their scope of practice.

using the most advanced diagnostic testing to identify the root causes, a completely personalized treatment protocol is designed

Supports

The general framework that advanced diagnostics can help identify biologic subtypes, biomarkers, or treatment-responsive groups is consistent with precision medicine and evidence-based medicine. ^{[21][22][25][26]} Major reviews describe precision medicine as using genomic, molecular, and other patient-specific data to guide diagnosis and treatment, and emphasize companion diagnostics or biomarker-based stratification as key tools for matching treatments to patients. ^[24] Evidence-based medicine also recognizes that diagnostic testing can inform downstream treatment decisions, but only when linked to patient-important outcomes and decision thresholds rather than assumed root-cause certainty. ^[23]

Contradicts

The specific claim is stronger than the evidence: it says the most advanced diagnostic testing identifies the root causes and a completely personalized treatment protocol is then designed. ^[21][23] Current literature supports personalized or stratified care in selected conditions, not complete personalization for all patients, and not definitive root-cause identification in most cases. ^[24] The kidney-health roadmap and other reviews emphasize gaps in care, research, and policy, showing that implementation of advanced diagnostics and individualized treatment remains incomplete and uneven. ^[22] Several cited items are protocols, not completed systematic reviews or trials, so they do not provide outcome evidence for the claim. Evidence-based diagnostic frameworks also caution that diagnostic tests must be evaluated by accuracy, clinical utility, and impact on outcomes, which is often missing for many advanced tests.

Mainstream view

The mainstream view is that advanced diagnostic testing can improve diagnostic precision and help tailor treatment in certain diseases, especially when there are validated biomarkers, molecular subtypes, or companion diagnostics. ^[23][25][26] However, the evidence does not support the sweeping claim that such testing can reliably identify the root causes of illness and generate a completely personalized treatment protocol for patients in general; in most settings care is still guided by probabilistic diagnosis, phenotype-based stratification, and partial personalization rather than fully individualized protocols. ^[21][22][24]

In their own wordsView sourceArchived copy

“using the most advanced diagnostic testing to identify the root causes, a completely personalized treatment protocol is designed”

Rule: Va. Code § 54.1-2900; 18VAC85-20-10